Alpha-fetoprotein response predicts treatment outcomes in patients with unresectable hepatocellular carcinoma receiving immune checkpoint inhibitors with or without tyrosine kinase inhibitors or locoregional therapies.Wei‐Fan Hsu, Cheng‐Yuan Peng, Po‐Heng Chuang et al.|PubMed|2021Cited by 19
Predictors of response and survival in patients with unresectable hepatocellular carcinoma treated with nivolumab: real-world experience.Wei‐Fan Hsu, Cheng‐Yuan Peng, Po‐Heng Chuang et al.|PubMed|2020Cited by 18